Cargando…

Significant muscle loss after stereotactic body radiotherapy predicts worse survival in patients with hepatocellular carcinoma

The relationship between sarcopenia and treatment outcomes, especially in patients with hepatocellular carcinoma (HCC) undergoing stereotactic body radiotherapy (SBRT) has not been well-explored. This study aimed to investigate the effects of sarcopenia on the survival and toxicity after SBRT in pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jen-Fu, Huang, Wen-Yen, Lo, Cheng-Hsiang, Lee, Meei-Shyuan, Lin, Chun-Shu, Shen, Po-Chien, Dai, Yang-Hong, Wang, Ying-Fu, Chen, Teng-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646692/ https://www.ncbi.nlm.nih.gov/pubmed/36352042 http://dx.doi.org/10.1038/s41598-022-21443-6

Ejemplares similares

Stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the treatment of hepatocellular carcinoma with portal vein invasion: a retrospective analysis
por: Yang, Jen-Fu, et al.
Publicado: (2019)

Prognostic Significance of Apparent Diffusion Coefficient in Hepatocellular Carcinoma Patients treated with Stereotactic Ablative Radiotherapy
por: Lo, Cheng-Hsiang, et al.
Publicado: (2019)

Dynamic Changes in Neutrophil-to-Lymphocyte Ratio are Associated with Survival and Liver Toxicity Following Stereotactic Body Radiotherapy for Hepatocellular Carcinoma
por: Hsiang, Chih-Weim, et al.
Publicado: (2021)

Survival and prognostic factors for patients with advanced hepatocellular carcinoma after stereotactic ablative radiotherapy
por: Lo, Cheng-Hsiang, et al.
Publicado: (2017)

Clinical outcome and pathologic correlation of stereotactic body radiation therapy as a bridge to transplantation for advanced hepatocellular carcinoma: a case series
por: Wang, Ying-Fu, et al.
Publicado: (2021)

Long-Term Breast Cancer Patient Outcomes After Adjuvant Radiotherapy Using Intensity-Modulated Radiotherapy or Conventional Tangential Radiotherapy
por: Yang, Jen-Fu, et al.
Publicado: (2016)

Radiomics-Based Predictive Model of Radiation-Induced Liver Disease in Hepatocellular Carcinoma Patients Receiving Stereo-Tactic Body Radiotherapy
por: Shen, Po-Chien, et al.
Publicado: (2022)

Radiosensitivity index emerges as a potential biomarker for combined radiotherapy and immunotherapy
por: Dai, Yang-Hong, et al.
Publicado: (2021)

Successful Treatment of Infantile Fibrosarcoma Spinal Metastasis by Chemotherapy and Stereotactic Hypofractionated Radiotherapy
por: Lo, Cheng-Hsiang, et al.
Publicado: (2013)

Vegetarian diet in dialysis patients: A significant gap between actual intake and current nutritional recommendations
por: Chen, Mei-Yin, et al.
Publicado: (2021)

Gene-associated methylation status of ST14 as a predictor of survival and hormone receptor positivity in breast Cancer
por: Dai, Yang-Hong, et al.
Publicado: (2021)

Efficacy of Stereotactic Body Radiotherapy in Patients With Hepatocellular Carcinoma Not Suitable for Transarterial Chemoembolization (HERACLES: HEpatocellular Carcinoma Stereotactic RAdiotherapy CLinical Efficacy Study)
por: Brunner, Thomas B., et al.
Publicado: (2021)

Stereotactic Body Radiotherapy vs. Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma: A Meta-Analysis
por: Pan, Yang-Xun, et al.
Publicado: (2020)

Comparison of clinical outcome between stereotactic body radiotherapy and radiofrequency ablation for unresectable hepatocellular carcinoma
por: Ji, Ren, et al.
Publicado: (2022)

Stereotactic Ablative Radiotherapy Fractionation for Hepatocellular Carcinoma in the United States
por: Sheth, Niki, et al.
Publicado: (2020)

Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma
por: Park, Jongmoo, et al.
Publicado: (2019)

Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: A Brief Overview
por: Matsuo, Yukinori
Publicado: (2023)

Effects of two different radiotherapies for craniopharyngiomas using stereotactic radiosurgery/ stereotactic radiotherapy or fractionated stereotactic radiotherapy
por: Kamogawa, Misaki, et al.
Publicado: (2022)

Novel application of stereotactic ablative radiotherapy using CyberKnife(®) for early-stage renal cell carcinoma in patients with pre-existing chronic kidney disease: Initial clinical experiences
por: LO, CHENG-HSIANG, et al.
Publicado: (2014)

Stereotactic body radiotherapy plus cetuximab for previously irradiated un-resectable head and neck cancer
por: Huang, Tai-Lin, et al.
Publicado: (2022)

Effectiveness of stereotactic ablative radiotherapy in patients with advanced hepatocellular carcinoma unsuitable for transarterial chemoembolization
por: Lee, Hsin-Lun, et al.
Publicado: (2019)

Stereotactic Radiotherapy for Hepatocellular Carcinoma, Radiosensitization Strategies and Radiation-Immunotherapy Combination
por: Pérez-Romasanta, Luis A., et al.
Publicado: (2021)

Stereotactic radiosurgery and stereotactic radiotherapy for brain metastases
por: Halasz, Lia M., et al.
Publicado: (2013)

Stereotactic Radiotherapy for Oligometastasis
por: Otake, Sotaro, et al.
Publicado: (2019)

Radiobiology of stereotactic radiotherapy
por: Mangoni, Monica, et al.
Publicado: (2022)

Comparison of local ablative therapies, including radiofrequency ablation, microwave ablation, stereotactic ablative radiotherapy, and particle radiotherapy, for inoperable hepatocellular carcinoma: a systematic review and meta-analysis
por: Cheng, Po-Lung, et al.
Publicado: (2023)

Hyponatremia Is Associated with Worse Outcomes from Fall Injuries in the Elderly
por: Kuo, Spencer C. H., et al.
Publicado: (2017)

Planning issues on linac-based stereotactic radiotherapy
por: Huang, Yang-Yang, et al.
Publicado: (2022)

Comparison of Combination Stereotactic Body Radiotherapy Plus High-Intensity Focused Ultrasound Ablation Versus Stereotactic Body Radiotherapy Alone for Massive Hepatocellular Carcinoma
por: Wang, Lei, et al.
Publicado: (2018)

Dosimetric comparison of carbon ion radiotherapy and stereotactic body radiotherapy with photon beams for the treatment of hepatocellular carcinoma
por: Abe, Takanori, et al.
Publicado: (2015)

Clinical outcomes of stereotactic body radiotherapy for spinal metastases from hepatocellular carcinoma
por: Lee, Eonju, et al.
Publicado: (2015)

Hepatocellular carcinoma with child Pugh-A Cirrhosis treated with stereotactic body radiotherapy
por: Hasan, Shaakir, et al.
Publicado: (2017)

Stereotactic Body Radiotherapy: Does It Have a Role in Management of Hepatocellular Carcinoma?
por: Choi, Seo Hee, et al.
Publicado: (2018)

Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study
por: Su, Ting-Shi, et al.
Publicado: (2021)

Symptom Distress and Quality of Life after Stereotactic Radiosurgery in Patients with Pituitary Tumors: A Questionnaire Survey
por: Yang, Ching-Ju, et al.
Publicado: (2014)

Stereotactic Body Radiotherapy for Primary Prostate Cancer
por: Kothari, Gargi, et al.
Publicado: (2018)

Association of Diet Quality and Vegetable Variety with the Risk of Cognitive Decline in Chinese Older Adults
por: Chou, Yi-Chun, et al.
Publicado: (2019)

Dosimetric comparison of different treatment modalities for stereotactic radiotherapy
por: Hsu, Shih-Ming, et al.
Publicado: (2017)

Stereotactic body radiotherapy combined with sintilimab in patients with recurrent or oligometastatic hepatocellular carcinoma: A phase II clinical trial
por: Chen, Yi-Xing, et al.
Publicado: (2023)

Volumetric Regression in Brain Metastases After Stereotactic Radiotherapy: Time Course, Predictors, and Significance
por: Oft, Dominik, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8me1g48aunhubkopv2umjtdthg